SCHEMBL2298641

SCHEMBL2298641

COC(=O)C[C@H](c1ccccc1)n1cnc2cc(NC(=O)Nc3ccccc3)ccc21

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 2/20 0.44
RAB9A P51151 11/20 0.43
NPC1 O15118 10/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
LMNA P02545 1/20 0.43
RECQL P46063 1/20 0.42
ADRA2B P18089 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPT P10636 4/20 0.41
HTT P42858 2/20 0.41
HSD17B10 Q99714 2/20 0.41
GLA P06280 1/20 0.41
EGFR P00533 1/20 0.40
NOTUM Q6P988 1/20 0.40
ALDH1A1 P00352 2/20 0.40
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2293498 0.92 NPC1 (0.41) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL2296414 0.91 MAPT (0.44) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL2296670 0.89 NR1I2 (0.47) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL2296252 0.89 NR1I2 (0.47) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL5300999 0.87 SMN1; SMN2 (0.50) RAB9ANPC1SMN1; SMN2LMNAKMT2A
SCHEMBL5299923 0.84 NR1I2 (0.44) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL12421967 0.83 NR1I2 (0.45) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL12420930 0.83 NR1I2 (0.45) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL5301184 0.83 RAB9A (0.44) NR1I2RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL2295162 0.83 FGFR1 (0.42) NR1I2RAB9ASMN1; SMN2KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO disclosed